Trial Profile
Evaluation of Perioperative Eltrombopag for the Management of Elective Surgery and Invasive Acts in Patients With Inherited Thrombocytopenia
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Nov 2023
Price :
$35
*
At a glance
- Drugs Eltrombopag (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- Acronyms ELPOT
- 14 Nov 2023 This trial has been completed, according to European Clinical Trials Database record.
- 02 Jan 2023 Planned End Date changed from 1 Aug 2022 to 1 Dec 2023.
- 02 Jan 2023 Planned primary completion date changed from 1 Aug 2022 to 1 Dec 2023.